Wan-Ching Chou

Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation

Pei‐Ling Hsieh, Pei‐Ming Chu, Hui‐Ching Cheng et al. · International Journal of Molecular Sciences · 2022 · 111 citations · Full text

Medicine, Oncology, Pharmacology +17

Quercetin Mitigates Cisplatin-Induced Oxidative Damage and Apoptosis in Cardiomyocytes through Nrf2/HO-1 Signaling Pathway

Shih‐Hao Wang, Kun‐Ling Tsai, Wan-Ching Chou et al. · The American Journal of Chinese Medicine · 2022 · 66 citations

Medicine, Cardiology, Pharmacology +16

Early Moderate Intensity Aerobic Exercise Intervention Prevents Doxorubicin-caused Cardiac Dysfunction through Inhibition of Cardiac Fibrosis and Inflammation

Hsin-Lun Yang, Pei‐Ling Hsieh, Ching‐Hsia Hung et al. · Cancers · 2020 · 51 citations · Full text

Medicine, Cardiology, Pharmacology +17

Galectin‐3 aggravates ox‐LDL‐induced endothelial dysfunction through LOX‐1 mediated signaling pathway

Hsiu‐Chung Ou, Wan-Ching Chou, Ching‐Hsia Hung et al. · Environmental Toxicology · 2019 · 46 citations

Life Sciences, Cell Biology, Molecular Medicine +15

Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK

Kun‐Ling Tsai, Pei‐Ling Hsieh, Wan-Ching Chou et al. · Cell & Bioscience · 2021 · 46 citations · Full text

Life Sciences, Cardiology, Pharmacology +17